Literature DB >> 10755533

Critical threshold of azathioprine dosage for maintenance immunosuppression in kidney graft recipients. Collaborative Transplant Study.

G Opelz1, B Döhler.   

Abstract

BACKGROUND: There are conflicting reports in the literature concerning the efficacy of maintenance immunosuppression in renal transplantation with a regimen of azathioprine and steroids.
METHODS: The daily dosage (mg/kg) of azathioprine administered 1 year after transplantation was analyzed in relation to subsequent long-term graft outcome. Transplants performed from 1985 to 1996 and reported to the Collaborative Transplant Study were analyzed.
RESULTS: In patients on maintenance immunosuppression without cyclosporine, the daily dosage of azathioprine had a highly significant influence on long-term graft outcome. Patients who received > 1.5 mg/kg/ day of azathioprine had a 69% graft survival rate at 7 years, compared with a 55% rate in patients receiving 1.01-1.5 mg/kg/day (P<0.0001) and a 45% rate in patients receiving < or = 1.00 mg/kg/day (P<0.0001). This observation was valid for patients who were taken off cyclosporine during the first year as well as for patients who were treated with azathioprine and steroids (without cyclosporine) from the beginning.
CONCLUSION: Maintenance immunosuppression with azathioprine and steroids results in good long-term kidney graft survival, provided azathioprine is administered at a daily dose of >1.5 mg/kg.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10755533     DOI: 10.1097/00007890-200003150-00025

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  3 in total

Review 1.  Present and Future Therapies in Neuromyelitis Optica Spectrum Disorders.

Authors:  Ingo Kleiter; Ralf Gold
Journal:  Neurotherapeutics       Date:  2016-01       Impact factor: 7.620

2.  Prospective randomized study of azathioprine vs cyclosporine based therapy in primary haplo-identical living-donor kidney transplantation: 20-year experience.

Authors:  Osama A Gheith; Mohamed A Bakr; Mohamed A Fouda; Ahmed A Shokeir; Mohamed Sobh; Mohamed Ghoneim
Journal:  Clin Exp Nephrol       Date:  2007-06-28       Impact factor: 2.801

3.  Azathioprine induction of tumors with microsatellite instability: risk evaluation using a mouse model.

Authors:  Sahra Bodo; Magali Svrcek; Isabelle Sourrouille; Peggy Cuillières-Dartigues; Tatiana Ledent; Sylvie Dumont; Laetitia Dinard; Philippe Lafitte; Camille Capel; Ada Collura; Olivier Buhard; Kristell Wanherdrick; Alexandra Chalastanis; Virginie Penard-Lacronique; Bettina Fabiani; Jean-François Fléjou; Nicole Brousse; Laurent Beaugerie; Alex Duval; Martine Muleris
Journal:  Oncotarget       Date:  2015-09-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.